Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
69,221.11
(
0.48%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JohnWayne

Send PM Follow Ignore
Followers 6
Posts 271
Boards Moderated 0
Alias Born 12/22/2011

JohnWayne

Re: dewophile post# 203185

Friday, 08/05/2016 12:47:03 PM

Friday, August 05, 2016 12:47:03 PM

Post# of 257268
Reminder that BMY combo trial is looking at chemo combo ONLY in PD-L1 non-expressors, which they estimate is 30% of population. MRK & ROG.VX are looking at chemo combos in broad population.

Curious what makes you think Opdivo + Yervoy is a long shot, I thought the Phase 1 data from ASCO were extremely impressive?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today